These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


143 related items for PubMed ID: 922403

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder.
    Etzioni A, Chaimovitz C, Levi Y, Benderli A, Better OS.
    Pediatr Res; 1980 Dec; 14(12):1395-7. PubMed ID: 7010289
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of Sar1-ala8-angiotensin II on blood pressure and renin in Bartter's syndrome, before and after treatment with prostaglandin synthetase inhibitors.
    Rudin A, Aurell M, Hansson L, Westberg G.
    Scand J Clin Lab Invest; 1979 Oct; 39(6):543-50. PubMed ID: 119300
    [Abstract] [Full Text] [Related]

  • 5. Effect of indomethacin upon the renin--angiotensin system in patients with Bartter's syndrome.
    Vierhapper H, Waldhäusl W.
    Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):119-24. PubMed ID: 6780358
    [Abstract] [Full Text] [Related]

  • 6. [Chronization by indomethacin of the circadian rhythm of blood renin and aldosterone in a case of Bartter's syndrome].
    Cugini P, Lucia P, Murano G, Letizia C, Panichi G, Adone G, Vetere AM, Magnanelli S.
    Minerva Urol Nefrol; 1985 Apr; 37(1):23-7. PubMed ID: 3901335
    [No Abstract] [Full Text] [Related]

  • 7. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
    Sasaki H, Kawasaki T, Okumura M, Asano T, Abe K, Arakawa K.
    Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Blood pressure fall by angiotensin II antagonist in patients with Bartter's syndrome.
    Kono T, Oseko F, Shimbo S, Nanno M, Ikeda F.
    J Clin Endocrinol Metab; 1976 Sep; 43(3):602-5. PubMed ID: 956346
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [A clinical study of pathophysiological feature of "Bartter's syndrome" (author's transl)].
    Sasaki H.
    Fukuoka Igaku Zasshi; 1979 Oct; 70(10):537-84. PubMed ID: 520995
    [No Abstract] [Full Text] [Related]

  • 14. Captopril and Bartter's syndrome.
    Sasaki H, Okumura M, Kawasaki T.
    Nephron; 1985 Oct; 41(3):303-4. PubMed ID: 3903530
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Indomethacin for Bartter's syndrome.
    Zancan L, Zacchello F, Mantero F.
    Lancet; 1976 Dec 18; 2(7999):1354. PubMed ID: 63823
    [No Abstract] [Full Text] [Related]

  • 17. Bartter's syndrome associated with Graves' disease and myasthenia gravis: report of a case.
    Inada M, Nishikawa M, Oishi M, Kurata S, Ogawa H, Sakurami T, Kono T, Imura H.
    Endocrinol Jpn; 1978 Oct 18; 25(5):485-92. PubMed ID: 581753
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Indomethacin in Bartter's syndrome].
    Valles M, Botey A, Bergada E, Revert L.
    Rev Clin Esp; 1978 Jun 30; 149(6):601-5. PubMed ID: 694140
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.